Skip to content

Short-term Ketogenic Diet as Compared With Conventional Long-term Trial in Refractory Infantile Spasms: A Randomized, Controlled Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00968136
Enrollment
Unknown
Registered
2009-08-28
Start date
Unknown
Completion date
Unknown
Last updated
2009-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infantile Spasms

Keywords

refractory infantile spasms

Brief summary

This is a randomized, controlled study to compare Short-term ketogenic diet with conventional long-term trial in refractory infantile spasms.

Interventions

None listed

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Months to 5 Years

Inclusion criteria

1. Patients, who have recalcitrant infantile spasms and undertake the ketogenic diet at Severance Hospital and Sanggye Paik Hospital from 2005 to 2008. 2. Clinical and electroencephalography findings are compatible with infantile spasms 3. Spasms are intractable to the initial combination of vigabatrin (150 mg/kg) and topiramate (10 mg/kg) and/or additional indicated anti-epileptic drugs including prednisolone (2 mg/kg for 2 weeks and an additional 2 weeks for tapering). 4. Study entry requires magnetic resonance imaging to confirm the absence of a progressive cerebral lesion.

Exclusion criteria

1. Patients who have a history of hyperlipidaemia and underlying metabolic diseases including acute intermittent porphyria, pyruvate carboxylase deficiency, and fatty acid oxidation defects. 2. Patients who have a history of nephrolithiasis.

Design outcomes

Primary

MeasureTime frame
Primary outcome measures include seizure relapse and frequency after successful completion of the ketogenic diet.Finally, 35 patients could be followed up for more than 12 months after successful discontinuation of the diet and then primary outcome will be measured.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026